Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * |
Title | Areteia Therapeutics - |
Description | Pioneering a new era in asthma Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic |
Keywords | N/A |
WebSite | areteiatx.com |
Host IP | 104.26.0.205 |
Location | United States |
Site | Rank |
US$1,470
Last updated: 2023-05-18 18:58:09
areteiatx.com has Semrush global rank of 0. areteiatx.com has an estimated worth of US$ 1,470, based on its estimated Ads revenue. areteiatx.com receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 104.26.0.205. According to SiteAdvisor, areteiatx.com is safe to visit. |
Purchase/Sale Value | US$1,470 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$40 |
Yearly Ads Revenue | US$488 |
Daily Unique Visitors | 11 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
areteiatx.com. | A | 300 | IP: 104.26.0.205 |
areteiatx.com. | A | 300 | IP: 172.67.74.91 |
areteiatx.com. | A | 300 | IP: 104.26.1.205 |
areteiatx.com. | AAAA | 300 | IPV6: 2a06:98c1:3122:a000:: |
areteiatx.com. | NS | 86400 | NS Record: athena.ns.cloudflare.com. |
areteiatx.com. | NS | 86400 | NS Record: vasilii.ns.cloudflare.com. |
areteiatx.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
areteiatx.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
areteiatx.com. | TXT | 300 | TXT Record: ppe-85b98ba515c7a8b2eb891c11e36b85904ec0ede6 |
areteiatx.com. | TXT | 300 | TXT Record: MS=ms40902238 |
areteiatx.com. | TXT | 300 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com ip4:147.160.167.0/26 include:_spf.psm.knowbe4.com ~all |
areteiatx.com. | TXT | 300 | TXT Record: google-site-verification=ySr6AUkOHXp7NAYIuLFpcajnq9g3mfRUlTaip_hvu6U |
= 50 ? scrolledFromTop = true : scrolledFromTop = false; st = window.pageYOffset || document.documentElement.scrollTop; if (st > lastScrollTop && window.pageYOffset >= 50 && !mobileMenuOpen) { console.log(’scroll down event! past pageYOffset 50! ’ + scrolledFromTop); showNav = false; } else {showNav = true;} lastScrollTop = st <= 0 ? 0 : st;" x-show="showNav" x-transition:enter="transition ease-linear duration-300" x-transition:enter-start="transform -translate-y-40" x-transition:enter-end="transform translate-y-0" x-transition:leave="transition ease-linear duration-300" x-transition:leave-start="transform translate-y-0" x-transition:leave-end="transform -translate-y-40" x-cloak @keydown.escape="mobileMenuOpen = false" > Home Pioneering a New Era In Asthma Control Our Advanced Candidate: Dexpramipexole Who We Are About Us Eosinophilic Asthma Our Science A New Approach How Did We Get Here? Phase 3 Development Program News News Releases Publications Presentations Contact |
HTTP/1.1 301 Moved Permanently Date: Fri, 15 Jul 2022 08:42:09 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Fri, 15 Jul 2022 09:42:09 GMT Location: https://areteiatx.com/ Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=zuXTYFFsZSMRaaduMHNhEk6QZQ90fTUp1nnZ%2FNZ1uykhNe3lUt9KfvuizpMWccCSCHnzYImFe5DpT43t2ehYxIBLxR6900E7UWN1CNNZPg70HE8mfDZEzssoSwv1UC8kySMK3eabK6YbqWA%3D"}],"group":"cf-nel","max_age":604800} NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} Server: cloudflare CF-RAY: 72b134032a814995-DME HTTP/2 200 date: Fri, 15 Jul 2022 08:42:10 GMT content-type: text/html; charset=UTF-8 x-powered-by: PHP/8.1.7 cache-control: no-cache, private set-cookie: XSRF-TOKEN=eyJpdiI6IlliRFJPYnBCT1dWZ0lqdTNVWkVBT3c9PSIsInZhbHVlIjoiYmhJbm9CWUZEa2NKMFhUZGZWdGlZWXJvN0xnSEJHQUZYRStFdWs2TEZmdDJVVmRodVE1TExQV2JReXhuVkljdllSa3ZtRXhpL3hCOW16d1gzMm9acXVCMHhNSGI3TnNYdVNTTG9Lb0tUNkQzNHdvc3FnNzdCOS9UanRkWkpIOEYiLCJtYWMiOiJjODhmZmNmMDg4Nzg4Y2Q1Y2FkYzM2NTlkYTE0NTg5MjAyMDRlZmJhNzlkYmI2MzM5YzU3OGJiYzAyZGVkZmZiIiwidGFnIjoiIn0%3D; expires=Fri, 15 Jul 2022 10:42:10 GMT; Max-Age=7200; path=/; samesite=lax set-cookie: areteia_session=eyJpdiI6ImJYanRGTWlwc0tMS0RkVFlQTTgxNUE9PSIsInZhbHVlIjoiSUVDRHlxbHl3ZURadFIrSFZqdzZJRzRUQWN1VUNzR09yV0tIdk51c21GeG1yTndWUXhNelEvU1NpZFpaR3hjRDdOWUZlWmMybVY4aXZ0VmErNnB4OURHVDY0RXNtUmcrZWJaY0dveTRJZmZhR25VS2pJZnBSTExRaU9JeUc5Z3MiLCJtYWMiOiIxZTBmZjEzMzBmMmY2MGJkMjg5OGYyZjVmYjE5MDU0N2QyM2U5NmY3M2RlZGRhYTgwZDI5NWM0M2MwNTkwZGQyIiwidGFnIjoiIn0%3D; expires=Fri, 15 Jul 2022 10:42:10 GMT; Max-Age=7200; path=/; httponly; samesite=lax vary: Accept-Encoding cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=oKUanArmJFMJbLO2Sn2U45xbqTmRisg%2FOwnaVsoqc7Kol4Bs6jztZSHKEjYDDUGl3jiTEgcmOz6pjk5NIGVchdY%2FojCZ8owcgEahvF8cBbfkTLJdrSbXRzRkrUTLghPtDiwAfwyVT1LjSFg%3D"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} server: cloudflare cf-ray: 72b13403d8139d99-DME |
Domain Name: ARETEIATX.COM Registry Domain ID: 2687749234_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-06-14T04:28:39Z Creation Date: 2022-04-08T15:36:33Z Registry Expiry Date: 2024-04-08T15:36:33Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ATHENA.NS.CLOUDFLARE.COM Name Server: VASILII.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-07-15T08:39:22Z <<< |